1Semenovsky ML,Shumakov VI,Sharov VG,et al.Protection of ischemic myocardium by exogenous phosphocreatine.II . Clinical ,ultrastructural , and biochemical evaluations[].Journal of Thoracic and Cardiovascular Surgery.1987
2Diaco M,Di Sesa VJ,Sun Shuching,et al.Cardioplegia for the immature myocardium[].Journal of Thoracic and Cardiovascular Surgery.1990
3Jonas RA.Myocardial protection for neonate and infants[].The Thoracic and Cardiovascular Surgeon.1998
4Robinson LA,Brainbridge MV,Hearse DJ.Creatine Phosphate :an additive myocardial protective and antiarrhythmic agent in cardioplegia[].Journal of Thoracic and Cardiovascular Surgery.1984
5Katz AM.Metabolism of the failing heart[].Cardioscience.1993
6Rosenshtraukh LV,Witt RC,Nance PN,et al.Electrophysiologic effects of exogenous phosphocreatine in cardiac tissue: potential antiarrhythmic actions[].American Heart Journal.1990
5Cuccurullo L, Accardo M, Agozzino L, et al. Ultrastructural pathology of pediatric myocardium in acute ischemia: bioptic study before and after treatment with cardioplegic solution[J]. Ultrastruct Pathol, 2006, 30(6):452-460.
6Sundgren NC, Giraud GD. Angiotensin Ⅱ stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes[J]. Physiol, 2003,548(3):881-891.
7Kempsford RD, Hearse DJ. Protection of the immature heart [J]. Thorac Cardiovasc Surg, 1990,99:269.
